Hospital-acquired infection
of cases related with medical devices
Antibiotic-resistant bacteria
deaths in Europe each year
Antibiotic resistance
deaths expected worldwide by 2050
OUR STORY
SPARTHA Medical is a spin-off from INSERM UMR1121 a public research institute with more than 20 years of experience in development of engineered coatings.
SPARTHA Medical’s core technologies are patented-based inventions coming from two European projects (IMMODGEL and PANBioRA) that started in 2013.
OUR TEAM
Our Multidisciplinary Team brings together Know-How and Expertise
| Medical Device Design and Development
| Coating Technologies
| BioTechnology Business Development
| Production and Regulatory Affairs
OUR SUPPORTS
Spartha Medical has a strong support from :
| University of Strasbourg | SATT Conectus | INSERM| Biovalley France.
We financially supported by | Grand Est region (Start-up support) | French Public Bank of Investment (BPI France, i-Lab 2019) | and European Union
OUR PAGE ON STRASBOURG’S BIOMEDECINE CENTRE, WHERE OUR LABS ARE
Spartha Medical: Bio Intelligent Innovation for a Sustainable Future At Spartha Medical, we believe materials can do more than just exist, they can adapt, respond, and protect. Our mission is to turn that belief into reality with bio-intelligent surfaces designed … Read More
4D-EASLEE Project Launch 4D-EASLEE: Launching a New Era of bio||intelligent Infection Prevention for CIED (Cardiac Implantable Electronic Devices) We are thrilled to share that Spartha Medical is one of three partners in 4D-EASLEE, a Eurostars1 supported collaborative project that officially … Read More
At Spartha Medical, collaboration and bio-intelligence are at the heart of our mission to develop groundbreaking solutions that transform industries and improve lives. By drawing inspiration from nature, we create smart, adaptive coatings designed for versatility, customization, and optimized safety. … Read More
Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Directorate-General for Communications Networks, Content and Technology. Neither the European Union nor the granting authority can be held responsible for them.